secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oruka Therapeutics, Inc. (ORKA)
CIK:        0000907654
Form:       8-K
Filed at:   2024-08-27T23:59:59+00:00
Accession:  0001213900-24-072683
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ARCA sets special dividend at $1.613/share for Oruka merger; ex-date Aug 29
---------------------------------------------------------------------------

- Special cash dividend of $1.613 per share payable on Aug 28 to holders of record Aug 26.
- Ex-dividend date set for Aug 29 due to dividend exceeding 25% of stock price; due bill period Aug 25-28.
- Merger with Oruka Therapeutics expected to close Aug 29; combined company to trade as ORKA on Nasdaq Global Market.
- Reverse stock split at 1-for-12 effective Sept 3, 2024, after merger close.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/907654/000121390024072683/0001213900-24-072683-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/907654/000121390024072683/ea0212462-8k425_arcabio.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-072683

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer